UBS Group’s Tenon Medical TNON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-119
Closed -$2.86K – 10389
2026
Q1
$3.03K Sell
119
-62
-34% -$1.83K ﹤0.01% 9154
2025
Q4
$6.02K Buy
181
+119
+192% +$4.79K ﹤0.01% 8595
2025
Q3
$2.57K Sell
62
-275
-82% -$11.7K ﹤0.01% 9152
2025
Q2
$11.5K Sell
337
-46
-12% -$1.76K ﹤0.01% 8781
2025
Q1
$28.3K Buy
383
+318
+489% +$17.9K ﹤0.01% 7984
2024
Q4
$4.31K Buy
+65
New +$6.67K ﹤0.01% 8766
2024
Q3
– Hold
0
– -$20 – 10066
2024
Q2
– Hold
0
– – – 9308
2024
Q1
– Hold
0
– -$158 – 10017
2023
Q4
– Hold
0
– – – 8858
2023
Q2
– Sell
-1
Closed -$3.66K – 9656
2023
Q1
$3.66K Hold
1
– – ﹤0.01% 8292
2022
Q4
$3.96K Buy
+1
New +$5.1K ﹤0.01% 9420

Other funds holding TNON

UBS Group's TNON Position: Q2 2026 in Review

UBS Group sold out of Tenon Medical (TNON) in Q2 2026, closing a stake of 119 shares — an estimated $2.86K sold.

UBS Group first reported a position in TNON in Q4 2022 and held it in 8 quarters. The position peaked at $28.3K in Q1 2025. 16 funds tracked by Wall St. Rank hold TNON as of Q2 2026.

  • UBS Group reported no remaining Tenon Medical position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 119 Tenon Medical shares in Q2 2026, an estimated $2.86K.
  • UBS Group first reported a position in Tenon Medical in Q4 2022 and held it in 8 quarters.
  • UBS Group's Tenon Medical position peaked at $28.3K in Q1 2025.
  • 16 funds tracked by Wall St. Rank held Tenon Medical as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.